NDC 11014-0566 - YONSA
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 11014-0566
- Package NDCs from labels
- 11014-0566-1
- Manufacturer
- Catalent Pharma Solutions, LLC | Catalent Greenville, Inc. | Sterling Chemical Malta Ltd
- Effective date
- 2025-09-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| YONSA (abiraterone acetate) tablets | Catalent Pharma Solutions, LLC | Catalent Greenville, Inc. | Sterling Chemical Malta Ltd | 2025-09-22 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 11014-0566 | YONSA (ABIRATERONE ACETATE) TABLET [CATALENT PHARMA SOLUTIONS, LLC] | 3 | Unmatched | 20231117_ec93b41f-88c2-e7ab-e053-2a95a90a636d.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Abirtega | ABIRATERONE ACETATE | CivicaScript, LLC | 2f932015-28b2-4f44-ac04-772e982e13e9 | 2025-02-28 | Warnings, Adverse reactions | EM5OCB9YJ6 |
| Abiraterone Acetate | ABIRATERONE | American Health Packaging | b36bff33-595e-4827-9a73-85c6954c314c | 2025-02-26 | Warnings, Adverse reactions | EM5OCB9YJ6 |
| Abiraterone acetate | ABIRATERONE ACETATE | Florida Pharmaceutical Products, LLC | 68121a71-5024-4f9e-bd9c-2d412f6a6355 | 2025-01-12 | Warnings, Adverse reactions | EM5OCB9YJ6 |
| Abiraterone | ABIRATERONE ACETATE | Hikma Pharmaceuticals USA Inc. | be29365a-ed25-44c0-9818-e9016dc95ba6 | 2024-12-20 | Warnings, Adverse reactions | EM5OCB9YJ6 |
| Abiraterone acetate | ABIRATERONE ACETATE | Rising Pharma Holdings, Inc. | 54ae5ef9-aea5-484a-a473-863b1397e206 | 2024-09-05 | Warnings, Adverse reactions | EM5OCB9YJ6 |
| Abiraterone | ABIRATERONE ACETATE | Quallent Pharmaceuticals Health LLC | 6f5b628b-69da-4a04-a4d5-623b18d1fd5d | 2024-07-16 | Warnings, Adverse reactions | EM5OCB9YJ6 |
| Abiraterone Acetate | ABIRATERONE ACETATE | NorthStar Rx LLC | 39434b24-bf64-f5c9-fbb6-b0d225099424 | 2023-12-26 | Warnings, Adverse reactions | EM5OCB9YJ6 |
| Abiraterone Acetate | ABIRATERONE ACETATE | Bryant Ranch Prepack | 79082b18-adde-4ffb-832a-b8c1d030c413 | 2023-12-07 | Warnings, Adverse reactions | EM5OCB9YJ6 |
| abiraterone acetate | ABIRATERONE ACETATE | Apotex Corp. | 9ce9d926-ef3a-4b22-a703-f49c18eb4e3d | 2023-10-18 | Warnings, Adverse reactions | EM5OCB9YJ6 |
| Abiraterone Acetate | ABIRATERONE ACETATE | Dr. Reddys Laboratories Inc | 7eda0d98-c2ba-c117-b757-1f566292e789 | 2023-09-04 | Warnings, Adverse reactions | EM5OCB9YJ6 |
| Abiraterone Acetate | ABIRATERONE | Amneal Pharmaceuticals NY LLC | c9eb9b46-f847-40a8-802c-a51b40406d5a | 2023-08-14 | Warnings, Adverse reactions | EM5OCB9YJ6 |
| abiraterone acetate | ABIRATERONE ACETATE | Florida Pharmaceutical Products, LLC. | b3e7f851-4132-4003-8f14-0eea21e5009c | 2023-04-28 | Warnings, Adverse reactions | EM5OCB9YJ6 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.